Morgan Stanley
BMED icon

Morgan Stanley’s BlackRock Future Health ETF BMED Stock Holding History

Morgan Stanley’s Portfolio BMED Stock Details BMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-710
Closed -$18.7K – 7858
2024
Q1 		$18.7K Buy
+710
New +$18K ﹤0.01% 6510

Other funds holding BMED

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return
BFEC
Benjamin F. Edwards & Company St. Louis, Missouri $5.69B AUM 15.37% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley's BMED Position: Q2 2024 in Review

Morgan Stanley sold out of BlackRock Future Health ETF (BMED) in Q2 2024, closing a stake of 710 shares — an estimated $18.7K sold.

Morgan Stanley first reported a position in BMED in Q1 2024 and held it in 1 quarter. The position peaked at $18.7K in Q1 2024. 5 funds tracked by Wall St. Rank hold BMED as of Q2 2024.

  • Morgan Stanley reported no remaining BlackRock Future Health ETF position as of Q2 2024 after selling out during the quarter.
  • Morgan Stanley sold 710 BlackRock Future Health ETF shares in Q2 2024, an estimated $18.7K.
  • Morgan Stanley first reported a position in BlackRock Future Health ETF in Q1 2024 and held it in 1 quarter.
  • Morgan Stanley's BlackRock Future Health ETF position peaked at $18.7K in Q1 2024.
  • 5 funds tracked by Wall St. Rank held BlackRock Future Health ETF as of Q2 2024.

Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.